Feola, Tiziana http://orcid.org/0000-0003-1066-0064
Cozzolino, Alessia http://orcid.org/0000-0001-8614-5873
De Alcubierre, Dario http://orcid.org/0000-0001-5242-1761
Pofi, Riccardo http://orcid.org/0000-0001-7808-5735
Galea, Nicola http://orcid.org/0000-0003-4708-5120
Catalano, Carlo http://orcid.org/0000-0003-4208-9691
Simeoli, Chiara http://orcid.org/0000-0003-4275-337X
Di Paola, Nicola
Campolo, Federica http://orcid.org/0000-0002-9290-874X
Pivonello, Rosario http://orcid.org/0000-0002-9632-1348
Isidori, Andrea M. http://orcid.org/0000-0002-9037-5417
Giannetta, Elisa http://orcid.org/0000-0003-3614-6151
Article History
Received: 22 March 2024
Accepted: 29 April 2024
First Online: 22 May 2024
Compliance with ethical standards
:
: RPi has received research support to Università Federico II di Napoli as a principal investigator for clinical trials from Novartis Pharma, Recordati, Strongbridge Biopharma, Corcept Therapeutics, HRA Pharma, Shire, Takeda, Neurocrine Biosciences, Camurus AB, and Pfizer, has received research support to Università Federico II di Napoli from Pfizer, Ipsen, Novartis Pharma, Strongbridge Biopharma, Merk Serono, and Ibsa, and received occasional consulting honoraria from Novartis Pharma, Recordati, Strongbridge Biopharma, HRA Pharma, Crinetics Pharmaceuticals, Corcept Therapeutics, Pfizer, and Bresmed Health Solutions. AMI has been a consultant for Novartis, Takeda, Recordati, and Sandoz companies and has received unconditional research grants from Shire, IPSEN, and Pfizer. All the other authors have nothing to disclose.
: The authors affirm that human research participants provided informed consent for publication of the images in Fig. .
: All patients provided written informed consent after fully explaining the purpose and nature of all procedures used. The study was approved by the Ethical Committee of Policlinico Umberto I (ref. number 4245). The study has been performed according to the ethical standards of the 1964 Declaration of Helsinki and its later amendments.